Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (16 quarters reported)
$438M in Q4 2020 → $43.5M now. Hover for any quarter.
As reported for the quarter ended September 30, 2024. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Biontech Se | 40.6% | Unchanged | 148,674 | $17.7M |
| Vir Biotechnology Inc | 26.8% | Unchanged | 1,559,142 | $11.7M |
| Exscientia | 17.8% | Unchanged | 1,590,909 | $7.76M |
| Curevac N V | 10.6% | Trimmed 1.8% | 1,568,866 | $4.61M |
| Butterfly Network Inc | 4.1% | Unchanged | 1,011,003 | $1.79M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2024 · filed November 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Curevac N V | Trimmed | −28,771 | −$84.6K | 10.6% |
quarter ended June 30, 2024 · filed November 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IH Immuncore Hldgs PLC | Exited | −576,923 | −$37.5M | — |
| Lumiradx Ltd | Exited | −14,285,714 | −$143K | — |
| Atreca Inc | Exited | −912,642 | −$73K | — |
quarter ended March 31, 2024 · filed May 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Curevac N V | Trimmed | −28,306 | −$119K | 8.0% |
quarter ended December 31, 2023 · filed February 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Amyris Inc | Exited | −292,398 | −$17.5K | — |
quarter ended September 30, 2023 · filed November 13, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Atreca Inc | Trimmed | −19,173 | −$4.99K | 0.3% |
quarter ended June 30, 2023 · filed August 14, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Atreca Inc | Trimmed | −74,764 | −$73.3K | 0.7% |
quarter ended March 31, 2023 · filed May 12, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Atreca Inc | Trimmed | −199,518 | −$227K | 1.0% |
quarter ended December 31, 2022 · filed February 14, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Curevac N V | Trimmed | −83,838 | −$506K | 7.6% |
| Z Zymergen Inc | Exited | −59,970 | −$200K | — |
| Atreca Inc | Trimmed | −114,783 | −$91.8K | 0.7% |
Loading...
